Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials [Phase 2]
Phase 2 long-term extension trial in participants with atopic dermatitis; the study was terminated with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 study evaluated the safety and efficacy of bermekimab in patients with moderate to severe atopic dermatitis; results have been …
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis [Phase 2, Phase 3]
A clinical trial update evaluating the efficacy and safety of topical SHR0302 ointment for mild-to-moderate atopic dermatitis across Phase 2…
-
CLINICAL_TRIALS trial_result · 2023-08-28Clinical Trial Update: A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) [Phase 3]
Phase 3 trial evaluating lebrikizumab for vaccine response in adults with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 study evaluating lebekizumab (LY3650150) plus topical corticosteroids in Japanese adults with moderate-to-severe atopic dermatitis c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial assessing EDP1815 for mild to severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: The Study of CM326 in Adult Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for CM326 in adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating CBP-201 for efficacy and safety in adults with moderate-to-severe atopic dermatitis has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for TQH2722 injection in moderate to severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. [Phase 2]
Phase 2 trial of LEO 138559 in adults with moderate-to-severe atopic dermatitis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Tacrolimus Versus Hydrocortisone in Atopic Dermatitis [Phase 4]
Phase 4 clinical trial comparing tacrolimus to hydrocortisone for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis [Phase 4]
Phase 4 study evaluating dupilumab's effect on pruritus neuro-mechanisms in adults with atopic dermatitis; results completed and posted in 2…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating Modified Huang-Lian-Jie-Du Decoction for atopic dermatitis in children; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis [Phase 3]
Phase 3 study of baricitinib in children and adolescents with atopic dermatitis has results posted; the trial is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis [Phase 3]
Phase 3 trial of baricitinib in children and adolescents with atopic dermatitis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating benralizumab for moderate to severe atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]
First-in-human proof-of-concept study of BEN2293 in mild to moderate atopic dermatitis completed.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Advantan for maintenance treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of SCM-AGH in moderate to severe atopic dermatitis has been completed.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis [Phase 2]
Phase 2 dose-escalation trial evaluating different concentrations of ZK 245186 in atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of the oral agent SHR0302 in subjects aged 12 years and older with moderate to sev…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating efficacy, safety, and pharmacokinetics of etokimab (ANB020) in adults with moderate-to-severe atopic dermatitis com…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of bermekimab for adult atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update describing pharmacodynamic blood characteristics of ICP-332 in patients with moderate to severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants [Phase 3]
Phase 3 trial update for the PEBBLES study evaluating a preventive strategy for eczema and food allergy in high-risk infants.